Objectives: Neutral endopeptidase (NEP) inhibition potentiated the renal action of Atrial Natriuretic Peptide (ANP) and was associated with appearance of the peptide in the urine, providing evidence of protection of the filtrated peptide along the course of the nephron. The macula densa, composed of epithelial cells, receives ionic information from the urinary compartment via Na-K-2Cl cotransport and influences renin secretion by the myoepithelioıd cells in the afferent arteriole. bNOS constitutively expressed in the epithelial cells of the macula densa is involved in this feed-back. NEP inhibition was associated with the absence of any increase in renin secretion. The hypothesis is that potentiation of urinary ANP by NEP inhibition could limit renin secretion by directly or indirectly targeting the macula densa in vivo. Methods and results: We tested the interaction between NEP inhibition (candoxatril) and Na-K-2Cl inhibition (bumetanide) on electrolyte and ANP urinary excretion, renin secretion, macula densa activity (NADPH diaphorase activity and bNOS mRNA) and TSC-1 mRNA expression in the renal cortex and BSC-1 in the renal medulla of rats treated for 5 days. Bumetanide increased urinary electrolyte excretion whereas candoxatril did not. Candoxatril increased urinary ANP and cyclic GMP excretion. Bumetanide increased renin and aldosterone secretion whereas candoxatril decreased renin secretion. This effect on renin release was associated with an increase in macula densa NADPH diaphorase activity in the bumetanide-treated group which was blunted by candoxatril. Lastly, bumetanide increased TSC-1 mRNA expression in the cortex and this effect was blunted by candoxatril. Conclusion: These results suggest that potentiation of ANP by NEP inhibition could interfere with tubular function at different levels and limit renin secretion by a urinary pathway involving macula densa activity.
Introduction
proximal tubule [6, 7] . Therefore NEP inhibition increases the natriuretic response to ANP probably by potentiating Atrial and brain natriuretic peptides are bioactive pepthe endo-urinary action of the filtrated peptide. The tides, synthesised and secreted by the heart, vehiculed in appearance of the peptide in urine during NEP inhibition the plasma and targeting on renal function [1, 2] . In the [8, 9] gives evidence of such a pharmacological urinary heart, ANP release is stretch-dependent, sensing in this protection, and suggests a possible urinary action. way the body fluid status and participating in its homeostaIn the kidney, the macula densa appears to be a unique sis [3, 4] . ANP metabolism is partly dependent on the type of chemo-sensor for body fluid homeostasis [10] . The kidney (15%). In the kidney, the hydrosoluble, filtrated macula densa, composed of epithelial cells, senses urinary atrial natriuretic peptide (ANP) is degraded by neutral ionic load via the Na-K-2Cl cotransport and modulates endopeptidase (NEP) [5] an ecto-enzyme mainly expressed the secretion of renin by the myoepithelioıd cells in the in the apical brush border of the epithelial cells of the afferent arteriole. Neuronal NO synthase (bNOS) activity has been demonstrated to be present in the macula densa and is involved in the intercellular communications be-tween the macula densa, at the urinary pole, and renin and volume and electrolyte contents were measured during secretion by the afferent arteriole within the juxtaglomeru-5 days. lar apparatus [11] . ANP and NEP inhibition are pharmacoRats were killed on the sixth day, 4 h after bumetanide logical factors which are reputed to decrease renin secreand candoxatril administration. The blood was drawn and tion [12, 13] , but the mechanisms by which ANP potentiarapidly transferred into an ice-cold tube containing the tion by NEP inhibition may decrease renin release remain following protease inhibitors: 1 mg of EDTA, 500 kallikunclear. A direct action of ANP on renin secreting cultured rein inhibitor units of aprotinin, and 4.25 mg of phenyl- 25 cells has been demonstrated in vitro [14] . But early studies methylsulfonylfluoride (PMSF) at 10 M per ml of blood. have shown that intrarenal infusion of ANP did not inhibit
The blood was immediately centrifuged (4000 rpm) at 48C renin release in nonfiltering kidney [15] , and conversely for 15 min, and plasma was kept frozen at 2308C until ANP did not inhibit furosemide-induced renin release from subsequently analyzed. The kidneys of all rats were isolated afferent arterioles [16] .
excised, immediately dissected macroscopically into cortex The hypothesis of the present study was therefore that and medulla, frozen in liquid nitrogen, and kept at 2808C potentiation of filtrated ANP by NEP inhibition could, until used in RT-PCR assays. directly or indirectly by changing ionic load, interfere in All experimental protocols were performed in accordvivo, in the distal part of the nephron, with different ance with the recommendations of the French Accreditafunctions of the epithelial cells, particularly in the macula tion of Laboratory Animal Care (authorisation N8 00577). densa. For this purpose we have used bumetanide as a blocker of the Na-K-2Cl cotransport, acting via an endo-2.2. Biochemical assays urinary pathway, increasing renin secretion by dissociating 1 2 the urinary ionic load of Na and Cl from their epithelial Urinary volume was determined gravimetrically and intracellular signalling and intercellular communications in urinary flow (UV) was expressed in ml / 4 h and ml / 20 h. the juxtaglomerular apparatus [17] . We tested in vivo in Urine samples were supplemented with 100 ml containing rats, the interaction of NEP inhibition by candoxatril with 5 mg of EDTA and were then frozen at 2308C. Electrolyte bumetanide-induced renin secretion. Because neuronal NO concentrations were measured in urine samples (100 ml) synthase is expressed in macula densa and involved in using an ion-selective electrode. The excretion rate for
macula densa feedback [11] , NADPH diaphorase activity Na (UNa), K (UK), and Cl (UCl) were calculated and was used as a specific marker of macula densa inexpressed in micromoles per 4 and 20 h respectively and volvement [18] in the interaction between ANP potentiapooled over 5 days. tion by NEP inhibition and renin secretion.
Urinary cGMP (U cGMP V) was measured by commercial radioimmunoassay kit (Amersham, Amersham, UK) in 3 diluted urine (1 / 50-1 / 200) with [ H]cGMP (assay range 2. Methods from 0.5 to 8 pmol) [9] . ANP was extracted by passing the plasma and urine 2.1. Experimental design samples (1 ml) through Sep Pak C cartridges (Millipore, 18 Milford, MA, USA) which were equilibrated by 0.2% Adult normotensive male Wistar rats (IFFA CREDO, ammonium acetate, pH 4 (4 ml), and eluted by 60% of France) weighing 145-170 g, were used in this study. Rats acetonitrile in ammonium acetate, pH 4. The supernatant were provided standard rat laboratory diet and water ad was transferred to a fresh tube and the extract was libitum. All the rats were placed in metabolic cages for at evaporated to dryness under a stream of nitrogen at 608C. least 3 days for adaptation before experimentation and
The dried extracts were dissolved in assay buffer and randomly allocated to four groups. One control group urinary ANP (U ANP V) was measured by radioim-125 received distilled water, and three treated groups received munoassay with I-(1-28)ANP (assay range from 3 to the drug solutions, bumetanide (Leo, les Ulis, France) at 10 200 pg) [19] . mg / kg, candoxatril (Pfizer, Sandwich, UK) at 50 mg / kg, Urinary aldosterone was extracted from urine by use of and bumetanide1candoxatril at 10 and 50 mg / kg respecBond Elut Phenyl Silice (Bondelut PH, Varian, Prolabo, tively. The bumetanide drug was administered by intraHarbour City, CA). The Bond Elut were pre-equilibrated peritoneal injection and the candoxatril drug was adminiswith 100% ethanol and bidistilled water solution before the tered by oral gavage at a volume of 5 ml / kg once a day urine was applied. After elution and evaporation to dryness during 6 days.
under a stream of air, the residue was reconstituted in The influence of circadian rhythm was avoided by assay buffer. The urinary aldosterone (U Aldo V) was starting all experiments at 09:00 A.M. Immediately after measured by radioimmunoassay by passing 3 gavage and intraperitoneal injection; the rats were in-[ H]aldosterone as tracer (assay range from 12.5 to 400 dividually housed in metabolic cages and allowed an ad pg) [20] and was determined by liquid scintillation countlibitum access to water and food. Urine was collected in ing using a Packard Tri-carb liquid scintillation analyzer. graduated cylinders during the first 4 h and the next 20 h Blood samples were taken for plasma renin activity (PRA) measurements. The plasma renin activity (PRA) quality was determined by running samples on 0.7% was measured by radioimmunoassay of the angiotensin I agarose gels stained with ethidium bromide, and RNA produced after incubation of 25 ml of plasma sample and concentration and purity were determined by the ultraviolet was expressed in nanograms of angiotensin I per milliliter (UV) light absorbance at 260 and 280 nm (Specper hour (AI / ml / h) [21] .
trophotometer U-2001, HITACHI).
Renal renin content was determined in renal cortical
Reverse transcription (RT) was carried out using 300 ng extracts by its capacity to generate angiotensin I (AI) using of total RNA from renal cortex or medulla of each rat. a specific radioimmunoassay for AI [22] . Plasma of Prior to RT reaction, the total RNA was primed with 1 mg bilateral nephrectomized rats was used as renin substrate.
of oligo d(T) (Pharmacia Biotech) and was heated at [12] [13] [14] [15] [16] [17] [18] Cortical renin activity was calculated using AI standards 658C for 10 min; then, the tubes were chilled on ice for 1 and expressed as micrograms of AI generated per hour per min. RT was performed at 378C for 60 min in a total milligram of cortical protein (mg AI / mg protein). Proteins volume of 18 ml, using 200 U of Moloney murine of cortical extracts were determined according to the leukemia virus reverse transcriptase (M-MLV reverse method of Bradford, with bovine serum albumin as transcriptase, Gibco-BRL, Life Technologies), 20 U RNase standard using a Bio-Rad Kit Laboratories.
inhibitor, 13RT buffer (75 mM KCl, 3 mM MgCl , 50 2 mM Tris-HCl, pH 8.3), 10 mM dithiothreitol (DTT) and 2.3. Histochemical staining of the macula densa 0.5 mM of each dNTP (Sigma).
For the histochemical demonstration of NADPH 2.6. Polymerase chain reaction diaphorase activity, 5 mm-thick cryostat kidney sections were incubated in 100 mM Tris / HCl buffer, pH 7.7
Part of the reverse transcription solution (3 ml) was containing nitroblue tetrazolium (NBT, 0.2 mM), bmixed with the PCR mix containing, 13Taq-buffer (1.5 NADPH (1 mM) and triton X-100 (0.2%). The exposure mM MgCl , 50 mM KCl, and 10 mM Tris-HCl, pH 8.3), 2 time was 30 min at 258C [18] . For semi-quantitative 1.25 U Taq DNA polymerase (Gibco-BRL, Life Techevaluation the density of NADPH diaphorase positive nologies), 0.05 mmol / l dNTP (Pharmacia), 10 pmol of 5 3 3 macula densa were expressed per 100 glomeruli [18] . sense and antisense primers and 4310 cpm of a PImmunohistochemistry of the neuronal bNO synthase radiolabelled mix of both primers. (bNOS) was performed on 7 mm paraffin sections [18] .
The samples were overlaid with 30 ml mineral oil, and After warming sections for 15 min in a microwave oven, PCR cycles were performed in a DNA thermal cycler they were incubated with protein blocking reagent (Techne GENIUS) with the following profile: initial (DAKO) to minimize spurius background staining. The denaturation 4 min at 948C, annealing 1 min at 628C for sections were then incubated with the primary rabbit rBSC1, rTSC1, and bNOS, and 1 min extension step at polyclonal antibody against bNOS (from Transduction 728C. The last cycle was followed by 1 min at 628C and a Laboratories) or with a non-immune IgG control (diluted final extension step of 10 min at 728C. The annealing 1 / 800) overnight at 48C. After washing sections, an temperature for glyceraldehyde-3-phosphate dehydrogenavidin-biotin peroxidase system kit (LSAB2 from DAKO) ase (GAPDH) primers was 558C. was used. The reaction was stopped in water and the Preliminary studies were performed to determine the sections coverslipped using Aquamount. optimum number of cycles for quantification. From this study, we chose the optimal number of cycles for each 2.4. Semiquantitative analysis of rBSC1, rTSC1, bNOS primer pair as follows: in renal cortex, 21 for rTSC1, 31 and rat renin mRNA expression for rNOS I, 23 for rRenin and 21 for GAPDH; in renal medulla, we chose 21 for rBSC1, and 21 for GAPDH. A The relative quantification of rat thiazide-sensitive Nanegative control sample (distilled water) was used for each Cl cotransporter (rTSC1), renin and neuronal NO synthase set of samples to check the reverse transcription and the (bNOS) mRNA expressions were assessed in renal cortex PCR amplification reagents for any contamination. PCR by comparative Reverse Transcriptase-Polymerase chain amplification was verified to be exponential.
reaction (RT-PCR). Rat bumetanide-sensitive Na-K-2Cl
To analyze the PCR products, each reaction was eleccotransporter (rBSC1) mRNA was similarly quantified in trophoresed in an 8% acrylamide / dihydroxyethylene the renal medulla.
bisacrylamide (29:1, vol:vol) gel in 13TBE buffer with a miniprotean II cell apparatus (Bio-Rad Laboratories).
Reverse transcription
Bands were stained with ethidium bromide and observed under UV light, cut out, suspended in 0.75 ml of periodic Extraction of total RNA from medulla and cortex of acid at 25 mM (ACROS ORGANIGS), incubated for 2 h at individual rat kidneys was performed according to the 508C, and the incorporated radioactivity was determined in manufacturer's directions with Trizol reagent (Gibco-BRL, The primer sequences for rBSC1, rTSC1, bNOS, rat There was no interaction between candoxatril and renin and glyceraldehyde-3-phosphate dehydrogenase bumetanide on diuresis, showing only a small additive (GAPDH) used in RT-PCR assays are reported in Table 1. effect. During the following 20 h only bumetanide induced These primers were custom obtained from Cybergene. The a small increase in diuresis (F55.2, P,0.05). rBSC1, rTSC1, bNOS and rat renin mRNA expressions
The urinary excretion of sodium, potassium, and chlowere calculated by normalizing to that of the 'housekeepride is represented in panels Fig. 1B The results were expressed as means6S.E.M. The the K excretion (two-way ANOVA, F514, P,0.05) experimental protocol was designed for using two-way during the first 4 h following administration of the 2 Analysis of Variance (ANOVA, Statview software). One compound. Candoxatril alone had no effect on Cl excrefactor was the NEP inhibitor effect; the second factor was tion but slightly increased bumetanide-induced chloruria in the bumetanide effect. This statistical approach permitted the first 4 h (interaction; F54.1, P50.05). During the us to test for an independent effect of each factor (NEPI following 20 h, bumetanide had no additive effect on and bumetanide) and for an interaction between the two natriuresis and chloruresis; only kaliuresis remained sigfactors. When the interaction was significant, comparison nificantly elevated under bumetanide (two-way ANOVA, between groups was performed by the Bonferroni method.
F55, P,0.05). Candoxatril had no effect on electrolyte When one parameter was measured several times during excretion during the subsequent 20 h. the experimental protocol an ANOVA for repeated measures was used. P,0.05 was considered significant.
Urinary excretion of ANP and cyclic GMP

Results
The urinary excretion of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) was mea-3.1. Diuresis and urinary electrolyte excretions sured on the first, the third, and the fifth days of treatment and expressed per 24 h. Fig. 2 shows that candoxatril Fig. 1 shows the mean effect of candoxatril and induced a significant increase in urinary excretion of ANP bumetanide on urinary excretion of water (Fig. 1A) and (two-way ANOVA, F5175, P,0.05). Moreover there was electrolytes (Fig. 1B-D) in the first 4 h after drug a significant interaction between candoxatril and administration and in the following 20 h for the 5 days of bumetanide (F59.2, P,0.05), bumetanide alone did not the experiment. Candoxatril significantly increased diuresis modify basal ANPuria, whereas it reduced the ANPuria during the first 4 h whether associated or not with induced by candoxatril (interaction, F59, P,0.05). Simibumetanide (F512, P,0.05, two-way ANOVA for relarly, candoxatril increased urinary cyclic GMP (F58.7, peated measures). Administration of bumetanide also P,0.05) whereas bumetanide had no effect (Fig. 2) . There increased diuresis during the first 4 h (F570, P,0.05).
was no interaction between the two treatments. Plasma ANP was also significantly increased by candoxatril (F5 Similarly the expression of renin mRNA in renal cortex 17, P,0.05) and did not change with bumetanide. demonstrated no difference between groups 4 h after the last administration of compounds (Fig. 3 ). 3.3. Renin-angiotensin-aldosterone system 3.4. NADPH activity and bNOS in macula densa Rats treated with bumetanide showed an increase in 24 h urinary excretion of aldosterone (ANOVA, F54.5, P,
In the bumetanide group, NADPH diaphorase activity 0.05) that reached a peak after 4 days of treatment (time appeared qualitatively more intense. Particularly, the area effect, F59, P,0.05) (Fig. 3) . No significant effect and and the intensity of each stained macula densa appeared no interaction on aldosteronuria was observed with canlarger in the bumetanide group compared to controls (Fig.  doxatril. 4A and B). Semiquantitative evaluation showed that The plasma renin activity (PRA) was measured at bumetanide alone significantly increased the density of sacrifice in all the animals 4 h after the last administration NADPH diaphorase activities in the macula densa of treatment. The results are represented in Fig. 3. (ANOVA, F586, P,0.05). There was a powerful signifiBumetanide significantly increased (ANOVA, F513, P, cant interaction between bumetanide and candoxatril (in-0.05) whereas candoxatril decreased PRA (ANOVA, F55, teraction, F531, P,0.05) demonstrating that the macula P,0.05). Therefore the plasma renin activity did not differ densa response to bumetanide was blunted by candoxatril. between controls and rats treated with the association of These data were confirmed by the specific immunohistocandoxatril1bumetanide. No significant difference was chemistry of the neuronal NOS (Fig. 4C) . observed between groups for renal renin content. NeverTwo-way ANOVA showed also a strong interaction theless we observed with bumetanide that the renin content between the two treatments on bNOS mRNA expression in showed a tendency to decrease rather than to increase, the renal cortex (interaction, F512, P,0.05). Bumetanide suggesting an acute increase in renin release (Fig. 3) .
alone increased bNOS mRNA expression as compared to rTSC1 mRNA expression which was blunted by candoxatril (Bonferroni, P,0.05).
Discussion
The present study was undertaken in order to test the hypothesis that urinary ANP potentiation induced by NEP inhibition could directly or indirectly alter epithelial function within the renal cortex, via modulation of the ionic urinary load delivered to the distal nephron. Because bumetanide is a specific inhibitor of Na-K-2Cl cotransport [23] , and because Na-K-2Cl (BSC1) is expressed at the apical pole of the epithelial cells directly sensing the urinary electrolyte load in the tubule lumen [24] , we investigated the pharmacological interaction between NEP inhibition by candoxatril and bumetanide in vivo. We have also used markers of epithelial function in the cortex, focusing our attention on the macula densa-dependent renin secretion.
As previously described, NEP inhibition is associated with a marked increase in ANP and cyclic GMP urinary excretion [8, 9, 25, 26] . In the present study, bumetanide alone had no effect on ANP and cGMP urinary excretion. Nevertheless, bumetanide significantly interacted with the NEP inhibitor to decrease urinary ANP excretion. This result probably reflects the decrease in ANP secretion by the heart and the consequent decrease in ANP filtration by the glomeruli in relation to the bumetanide-induced decrease in body fluid volume. Similarly, we have recently described an increase in urinary ANP excretion proportional to ANP secretion in congestive heart failure during NEP inhibition [27] .
ANP targets the particulate guanylate cyclases in the renal epithelial cells, inducing cyclic GMP production. varying density [28] . The particulate guanylate cyclase influenced (*, P,0.05) the three parameters. Bumetanide significantly appears to be expressed not only at the basolateral pole of interacted with candoxatril only in decreasing ANPuria ($, P,0.05) and the epithelial cells but also at the apical pole [29] , had no effect on plasma ANP and urinary cGMP; n5number of rats.
suggesting that urinary ANP, generated by glomerular filtration, and prevented from proximal degradation by other groups (Bonferroni, P,0.05). Candoxatril complete-NEP inhibition, could act on epithelial cell function by an ly prevented the increase in bNOS expression due to apical interaction. In contrast with acute inhibition of NEP bumetanide (Fig. 4) .
in rats during which plasma ANP did not increase [9] , chronic administration of candoxatril induced a significant 3.5. Renal rBSC1 and rTSC1 mRNA expressions rise in plasma ANP, not completely excluding a role for plasma ANP in the regulation of renin secretion. Neverth- Table 2 presents the mRNA expressions of rTSC1 in the less, although a direct action of ANP on renin-secreting renal cortex and rBSC1 in the medulla. Bumetanide had no cultured cells has been shown [14] , it has also been effect on rBSC1 mRNA expression in the renal medulla.
demonstrated that ANP did not influence renin secretion Candoxatril significantly increased the expression of from intact, isolated, rabbit afferent arterioles in basal rBSC1 mRNA (F57.5, P,0.05) in the medulla without conditions as well as after in vivo stimulation by interaction with bumetanide. In contrast, bumetanide and furosemide, another Na-K-2Cl inhibitor [16] . Similarly candoxatril interacted on cortical rTSC1 mRNA expression evidence of a direct effect of circulating ANP on small (F534.8, P,0.05); bumetanide alone increased cortical arteriole function has never been established in vivo Fig. 3 . Renin-aldosterone system parameters: 24 h aldosteronuria (UAldoV), plasma renin activity (PRA) at sacrifice, renal renin content (RRC), and cortical renin mRNA / GAPDH mRNA ratio. Bumetanide ($) increased aldosteronuria (P,0.05) independently of candoxatril which has no significant effect. Bumetanide ($) increased (P,0.05) whereas candoxatril (*) decreased (P,0.05) plasma renin activity without significant interaction. The variations in renal renin content and mRNA did not reach statistical significance; n5number of rats. [30, 31] . Therefore, we proposed the concept of the comAs expected, bumetanide increased the plasma level of partmented biodisponibility of ANP in vivo [32, 33] .
renin activity 4 h after the last injection of the compound. As expected, bumetanide, which blocks Na-K-2Cl Na-K-2Cl, the molecular target of bumetanide, is excotransport mainly in the thick ascending limb (TAL), pressed in the TAL but also in the macula densa [45] . In induced a marked rise in electrolyte excretion. Candoxatril the latter, Na-K-2Cl is probably the main molecular alone had a small additive effect on diuresis, no effect on effector of the link between luminal urinary ionic connatriuresis, a small additive effect on chloruria and a centration and juxta-glomerular apparatus function, consignificant, bumetanide-independent effect on kaliuresis.
trolling renin secretion [10] . Our results confirmed that 1 This could be due to a direct or indirect modulation of K bumetanide, by blocking the apical Na-K-2Cl activity in conductance [34] [35] [36] . These data show an escape from the macula densa [17, 46] , increased renin secretion, slight-ANP-dependent natriuresis during chronic inhibition of ly decreased renin storage, and probably increased renin NEP. That acute inhibition of renal NEP potentiates the synthesis in a delayed manner not assessed in the present natriuretic effect of ANP has been largely documented study. These data fit well with the time course of renal [25, 26, 37] , but the effect of chronic administration of NEP renin secretion and biosynthesis in response to furosemide inhibitors on natriuresis is less documented. As in conges- [47] and to other agents [48] . tive heart failure [38], characterized by a chronic increase
In contrast, NEP inhibition significantly decreased renin in ANP secretion [39, 40] , chronic NEP inhibition-induced secretion and prevented the increase induced by ANP potentiation probably induced escape from the natbumetanide. This observation suggests that urinary ANP riuretic effect of ANP. The mechanisms of ANP escape potentiation by NEP inhibition could influence directly or during chronic NEP inhibition remain to be explored but in indirectly, via the modulation of urine electrolyte concongestive heart failure both the induction of phosphocentration, probably mainly of chloride, the intracellular diesterase activity [41] [42] [43] and Na-K-2Cl overexpression signaling in the macula densa and intercellular communi- [44] have been reported.
cations through the juxta-glomerular apparatus. These Fig. 4 . Macula densa activity: NADPH diaphorase staining in control (A) and bumetanide (B) treated rats, and neuronal NOS immunohistochemistry in bumetanide treated rats (C). Bumetanide significantly increased both NADPH diaphorase activity and bNOS mRNA expression (P,0.05). Candoxatril significantly (P,0.05) interacted with bumetanide in decreasing both NADPH activity and bNOS mRNA expression. Therefore only the bumetanide group ($) differed from the other three groups (Bonferroni, P,0.05); n5number of rats.
present data fit well with an early study showing that out, salt sensitivity and renin secretion [49, 50] in mice. In intrarenal infusion of ANP in the nonfiltering kidney, these studies, despite the absence of alterations in cumulalacking a functional macula densa, did not change renin tive urinary excretion of electrolytes, Melo et al. [49, 50] secretion whereas it decreased renin secretion in filtering showed a lack of inhibition of renin secretion in response dog kidney [15] . It also fits well with the more recently to high salt intake in ANP knock-out mice. Therefore, our published results of the interactions between ANP knockresults of the combined treatment group with functional Table 2 Semi-quantitative (RT-PCR assay) of Na-K-2Cl (BSC-1) and Na-Cl (TSC-1) cotransporter mRNA expressions in the medulla and the cortex respectively, and of neuronal NO synthase (bNOS) mRNA expression in the cortex (statistical significance is given for the two-way ANOVA; $: bumetanide effect, *: candoxatril effect, P,0.05) In order to provide further support for this hypothesis,
